Abbott sues to block sales of drug in generic form before patents expire

Abbott Laboratories has sued to prevent Watson Pharmaceuticals Inc. from commercializing a generic version of the cholesterol drug Niaspan before the drug’s patents expire.

Read more.

What's New

BizPeople

Sponsored Content

BIZEXPO IS TOMORROW -  May 13 - Don't Miss Out!

Close the CTA

Holiday flash sale!

Limited time offer. New subscribers only.

Subscribe to BizTimes Milwaukee and save 40%

Holiday flash sale! Subscribe to BizTimes and save 40%!

Limited time offer. New subscribers only.